{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T08:20:32Z","timestamp":1784967632081,"version":"3.55.0"},"reference-count":8,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Stroke and Cerebrovascular Diseases"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.jstrokecerebrovasdis.2016.01.042","type":"journal-article","created":{"date-parts":[[2016,3,17]],"date-time":"2016-03-17T13:24:10Z","timestamp":1458221050000},"page":"e63-e65","source":"Crossref","is-referenced-by-count":9,"title":["Erdheim\u2013Chester Disease: An Unusual Cause of Intracranial Vasculitis and Progressive Leukoencephalopathy"],"prefix":"10.1016","volume":"25","author":[{"given":"Sharmila","family":"Sagnier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Debruxelles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Lepreux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Sibon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.042_bib0010","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1182\/blood-2014-03-561381","article-title":"Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease","volume":"124","author":"Diamond","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.042_bib0015","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12916-014-0221-3","article-title":"Clinical considerations and key issues in the management of patients with Erdheim-Chester Disease: a seven case series","volume":"12","author":"Mazor","year":"2014","journal-title":"BMC Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.042_bib0020","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1148\/radiol.10090320","article-title":"Cerebral, facial, and orbital involvement in Erdheim-Chester disease: CT and MR imaging findings","volume":"255","author":"Drier","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.042_bib0025","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1212\/WNL.0b013e3181c67bbc","article-title":"Characteristic brain MRI appearance of Erdheim-Chester disease","volume":"73","author":"Bianco","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.042_bib0030","first-page":"880","article-title":"MR imaging presentation of intracranial disease associated with Langerhans cell histiocytosis","volume":"25","author":"Prayer","year":"2004","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.042_bib0035","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1182\/blood-2010-06-294108","article-title":"CNS involvement and treatment with interferon-\u03b1 are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients","volume":"117","author":"Arnaud","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.042_bib0040","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1200\/JCO.2014.57.1950","article-title":"Reproducible and sustained efficacy of targeted therapy with vemurafenib in patients with BRAFV600E-mutated Erdheim-Chester disease","volume":"33","author":"Haroche","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2016.01.042_bib0045","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1182\/blood-2012-07-446286","article-title":"Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation","volume":"121","author":"Haroche","year":"2013","journal-title":"Blood"}],"container-title":["Journal of Stroke and Cerebrovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305716000732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305716000732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T04:21:26Z","timestamp":1536898886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1052305716000732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":8,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S1052305716000732"],"URL":"https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2016.01.042","relation":{},"ISSN":["1052-3057"],"issn-type":[{"value":"1052-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]}}}